A biochemical study on the level of lipids and glycoproteins in the serum and platelets of liver cirrhotic bleeders

• Autorzy: Vijayalakshmi S. , Geetha A. , Jeyachristy S.A.
• Języki publikacji: EN

Abstrakty

EN

Bleeding complication and abnormal platelet functions are associated with liver cirrhosis. The aim of the present investigation was to assess the functional integrity of platelets in terms of lipids like cholesterol and phospholipids, glycoproteins and membrane-bound enzymes. Liver cirrhotic patients with bleeding complications were studied. Age and sex matched normal healthy volunteers were also involved in this study as a control group. Levels of cholesterol, phospholipids, glycoproteins and adenosine triphosphatases were assessed in isolated platelet membrane fraction. The level of glycoproteins and the activity of adenosine triphosphatases were found to be decreased significantly in cirrhotic patients. The cholesterol/phospholipid ratio was found to be altered significantly, indicating an alteration in the fluidity of platelet membrane. The results of this study reveal that the functional impairment of platelets in liver cirrhotic patients which is responsible for their bleeding tendency might also be due to altered lipid and enzyme levels in platelet membrane.

Słowa kluczowe

EN

chronic disease; glycoprotein; lipid; liver disease; cirrhosis; abnormal nodule; liver; cholesterol; phospholipid; adenosine triphosphatase; platelet

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2006
• Tom: 53
• Numer: 1
• Opis fizyczny: p.213-220,ref.

Twórcy

autor

Vijayalakshmi S.

• Bharathi Women's College, North Chennai, Chennai, India

autor

Geetha A.

autor

Jeyachristy S.A.

Bibliografia

• Aalami OO, Allen DB, Organ CH Jr (2000) Chylous ascites: a collective review. Surgery 128: 761–778.
• Ahaneku JE, Taylor GO, Olubuyide IO, Agbedana EO (1992) Abnormal lipid and lipoprotein patterns in liver cirrhosis with and without hepatocellular carcinoma. J Pak Med Assoc 42: 260–263.
• Aster RH, Jandl JH (1964) Platelet sequestration in man. I. Methods. J Clin Invest 43: 843–855.
• Barlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–468.
• Bilbao JI, Quiroga J, Herrero JI, Benito A (2002) Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol 25: 251–269.
• Blaker H, Theuer D, Otto HF (2001) Pathology of liver cirrhosis and portal hypertension. Radiologe 41: 833–839.
• Bonting SL (1970) In Membranes and Ion Transport (Bitter E, ed) vol 1, pp 257–363, Elsevier, Amsterdam. Bowers GN Jr, Mc Comb RB (1975) Measurement of total alkaline phosphatase activity in human serum. Clin Chem 21: 1988–1995.
• Brulet P, McConnell HM (1976) Lateral hapten mobility and immunochemistry of model membranes. Proc Natl Acad Sci USA 73: 2977–2981.
• Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalophathy in patients with cirrhosis. J Hepatol 30: 890–895.
• Butterworth RF (2000) Complications of cirrhosis III – Hepatic encephalopathy. J Hepatol 32: (suppl 1) 171–180.
• Cohen JA, Kaplan MM (1979) The SGOT/AGPT ratio — an indicator of alcoholic liver disease. Dig Dis Sci 24: 835–838.
• Enouf J, Bredoux R, Bourdeau N, Sarkadi B, Levy-Toledano S (1989) Further characterization of the plasma membrane and intracellular membrane-associated platelet Ca2+ transport systems. Biochem J 263: 547–552.
• Evans DJ Jr (1969) Membrane adenosine triphosphatase of Escherichia coli: activation by calcium ion and inhibition by monovalent cations. J Bacteriol 100: 914–922.
• Fischer RA (1995) Analysis of larger samples. In Elements of Mathematical Statistics (Gupta SC, Kapoor VK, eds) pp 307, Sultan-Chand & Sons Publishers, New Delhi.
• Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66: 375.
• Glossmann H, Newille DM Jr (1971) Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem 246: 6339–6346.
• Goldberg DM (1980) Structural, functional and clinical aspects of gamma glutamyl transferase. Crit Rev Clin Lab Sci 12: 1–58.
• Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK (1999) Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 44: 754–758.
• Gubernick JA, Rosenberg HK, Ilaslan H, Kessler A (2000) US approach to jaundice in infants and children. Radiographics 20: 173–195.
• Hjerton S, Pan H (1983) Purification and characterization of two forms of a low affinity Ca2+-ATPase from erythrocyte membranes. Biochim Biophys Acta 728: 281–288.
• Hiramatsu S, Kojima J, Okada TT, Inai S, Ohmori K (1976) The serum protein profile in chronic hepatitis, cirrhosis, and liver cancer. Acta Hepatogastroenterol (Stuttg.) 23: 177–182.
• Homoncik M, Jilma-Stohlawetz P, Schmid M, Ferlitsch A, Peck-Radosavljevic M (2004) Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized double-blind, placebo-controlled study. Aliment Pharmacol Ther 20: 437–443.
• Italiano JE Jr, Bergmeier W, Tiwari S, Falet H, Hartwig JH, Hoffmeister KM, Andre P, Wagner DD, Shivdasani RA (2003) Mechanisms and implications of platelet discoid shape. Blood 101: 4789–4796.
• Ito K, Shiraki K, Sakai T, Yoshimura H, Nakano T (2005) Portal hypertensive colopathy in patients with liver cirrhosis. World J Gasteroenterol 11: 3127–3130.
• Jung DH, Parekh AC (1970) A new color reaction for cholesterol assay. Clin Chim Acta 35: 73–78.
• Khokhar N (2003) Serum aminotransferase levels and platelet count as predictive factor of fibrosis and cirrhosis in patients with chronic hepatitis C infection. J Pak Med Assoc 53: 101–104.
• King J (1960) A study of human serum transaminases. J Med Lab Technol 17: 1–21.
• Lind SE, Yin HL, Stossel TP (1982) Human platelets contain gelsolin. A regulator of actin filament lengths. J Clin Invest 69: 1384–1387.
• Niebes P (1975) Micromethod for the determination of glycosaminoglycans in the serum. Results from the serum of healthy and varicose subjects. Clin Chim Acta 62: 195–202.
• Nomura S, Komiyama Y, Matsuura E, Xie GL, Katsura K, Miyake T, Miyazaki Y, Kagawa H, Koike T, Fukuhara S (1996) Participation of αIIb β3 in platelet microparticle generation by collagen and thrombin. Haemostasis 26: 31–37.
• Odelowo OO, Smoot DT, Kim K (2002) Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc 94: 712–715.
• Ohnishi T, Suzuki T, Suzuki Y, Ozawa K (1982) A comparative study of plasma membrane Mg2+-ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta 684: 67–74.
• Pan Z, Wu XJ, Li JS, Liu FN, Li WS, Han JM (2004) Functional hepatic flow in patients with liver cirrhosis. World J Gasteroenterol 10: 915–918.
• Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Oscada J, Wysocka J (2001) Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta thromboglobulin and platelet factor-4. Hepatogastroenterology 48: 818–822.
• Polgreen PM, Fultz SL, Justice AC, Wagner JH, Diekema DJ, Rabeneck L, Weissman S, Stapleton JT (2004) Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people. HIV Med 5: 144–150.
• Powell LD, Cantley LC (1980) Structural changes in Na+K+ ATPase acompanying detergent inactivation. Biochim Biophys Acta 599: 436–447.
• Ramasamy I (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol 49: 1–35.
• Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS (1996) Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/chimeric 7E3 antibody. J Clin Invest 98: 863–874.
• Roughan PG, Batt RD (1968) Quantitative analysis of sulfolipid (sulfoquinovosyl diglyceride) and galactolipids (monogalactosyl and digalactosyl diglycerides) in plant tissues. Anal Biochem 22: 74–88.
• Ruggeri ZM, Savage B (1998) Biological functions of von Willebrand factor. In Von Willebrand Factor and the Mechanisms of Platelet Function (Ruggeri ZM, ed) pp 79, Springer-Verlag Publishers, Berlin.
• Schick PK, Tuszynski GP, Vander Voort PW (1983) Human platelet cytoskeleton: specific content of glycolipids and phospholipids. Blood 61: 163–166.
• Schiodt FV, Balko J, Schilsky M, Harrison ME, Thomton A, Lee WM; Acute liver failure study group (2003) Thrombopoietin in acute liver failure. Hepatology 37: 558–561.
• Sundar Rao PSS, Richard J (1999) In An Introduction to Biostatistics – a Manual for Students in Health Sciences. 3rd edn, pp 112–113, Asoke K Gosh Publishers, New Delhi.
• Tettamanti G, Bonali F, Marchesini, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296: 160–70.
• Wagner WD (1979) A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem 94: 394–396.
• Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234: 1971–1975.
• Whitfield JB, Pounder RE, Neale G, Moss DW (1972) Serum gamma-glutamyl transpeptidase activity in liver disease. Gut 13: 702–708.
• Winzler RJ (1955) Determination of serum glycoproteins. Methods Biochem Anal 2: 279–311.
• Xu CQ, Zeng YJ, Gregersen H (2002) Dynamic model of the role of platelets in the blood coagulation system. Med Eng Phys 24: 587–593.